SEC Form 4Coverage since Jun 11, 2026
$PBLS insider trading
Over the last 12 months, Parabilis Medicines insiders reported 5 buys totaling $441.4M and no sales across SEC Form 4 filings.
- Bought · 12m
- $441.4M 5 events
- Sold · 12m
- — 0 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $PBLS · 12Mvia TradingView
Top insiders · 12m
RA CAPITAL MANAGEMENT, L.P.—2× · $430.7M
SEBULSKY ALAN—2× · $724K
Levy Guy—1× · $10.0M
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▲ Buy | 244,593 | $28.29 | $6.9M | +0.9% | 6 tranches · indirect |
| Jun 15, 2026 | SEBULSKY ALAND | ▲ Buy | 17,500 | $27.06 | $474K | +140% | 3 tranches · indirect |
| Jun 11, 2026 | Levy Guy10% | ▲ Buy | 500,000 | $20 | $10.0M | +328.9% | late · 2 tranches · indirect |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P.D·10% | ▲ Buy | 21,188,750 | $20 | $423.8M | — | 2 tranches · indirect |
| Jun 11, 2026 | SEBULSKY ALAND | ▲ Buy | 12,500 | $20 | $250K | — | indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PBLS feed.